Skip to main content
Year archive

Immunovia — 2018 filings

All 29 regulatory filings released by Immunovia (IMMNOV) in 2018, sourced directly from the official regulator.

29 Filings
2018 Period
2018 filings (29)
Filing Released Lang
Interim / Quarterly Report 2018
Interim / Quarterly Report 9M 2018
2018-11-07 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report 9M 2018
2018-11-07 English
Valberedning utsedd inför årsstämma 2019 i Immunovia AB (Publ)
AGM Information
2018-10-26 Swedish
Immunovia AB (Publ) nomination committee appointed for AGM 2019
AGM Information
2018-10-26 English
Immunovia announces strategic focus centered on IMMray™ blood-based biomarker signatures for rheumatoid arthritis within autoimmunity
Regulatory Filings
2018-10-08 English
Immunovia annonserar strategiskt fokus på IMMray® blodbaserade biomarkörssignaturer för Reumatoid artrit inom autoimmuna sjukdomar
Regulatory Filings
2018-10-08 Swedish
Increase in share capital and number of shares in Immunovia
Share Issue/Capital Change
2018-09-28 English
Nytt aktiekapital och antal aktier i Immunovia
Share Issue/Capital Change
2018-09-28 Swedish
Immunovia Interim report, January-June 2018
Interim / Quarterly Report H1 2018
2018-08-24 English
Immunovia delårsrapport, januari-juni 2018
Interim / Quarterly Report H1 2018
2018-08-24 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report H1 2018
2018-08-24 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report H1 2018
2018-08-24 English
Breakthrough in autoimmune testing – IMMrayTM based novel biomarker signature identifies patients with anti-CCP negative rheumatoid arthritis
Regulatory Filings
2018-08-22 English
Genombrott inom autoimmun testning - en IMMray ™-baserad biomarkörssignatur identifierar patienter med anti-CCP-negativ reumatoid artrit
Regulatory Filings
2018-08-22 Swedish
Resultat från retrospektiv studie för IMMray® PanCan-d visar att Immunovia behöver utföra optimeringar för att uppfylla förväntad prestanda
Regulatory Filings
2018-08-16 Swedish
Retrospective study results for IMMray™ PanCan-d conclude Immunovia needs to do further optimizations to meet the expected performance
Regulatory Filings
2018-08-16 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-08-10 English
Förändring av antal aktier och röster i Immunovia AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2018-06-29 Swedish
Immunovia har genomfört en riktad nyemission om cirka 324 miljoner kronor
Share Issue/Capital Change
2018-06-08 Swedish
Immunovia has completed a directed share issue of approximately SEK 324 million
Share Issue/Capital Change
2018-06-08 English
Immunovia announces its intent to carry out a directed share issue
Capital/Financing Update
2018-06-07 English
Immunovia offentliggör avsikt att genomföra en riktad nyemission
Share Issue/Capital Change
2018-06-07 Swedish
Major Shareholding Notification 2018
Major Shareholding Notification
2018-06-04 English
Immunovia—report from AGM
AGM Information
2018-05-03 English
Immunovia Stämmokommuniké
AGM Information
2018-05-03 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report Q1 2018
2018-04-27 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report Q1 2018
2018-04-27 English
Annual Report 2017
Annual Report FY 2017
2018-04-04 Swedish
Annual Report 2017
Annual Report FY 2017
2018-04-04 English